Results 151 to 160 of about 26,593 (244)

Precision strikes: PSMA-targeted radionuclide therapy in prostate cancer - a narrative review. [PDF]

Front Oncol, 2023
Szponar P, Petrasz P, Brzeźniakiewicz-Janus K, Drewa T, Zorga P, Adamowicz J.   +5 more
europepmc   +1 more source

European Society of Neuroendocrine Tumors (ENETS) 2025 guidance paper for lung and thymic carcinoids

Journal of Neuroendocrinology, Volume 38, Issue 4, April 2026.
Abstract This ENETS guidance paper, developed by a multidisciplinary working group, provides up‐to‐date and practical advice on the diagnosis and management of lung and thymic carcinoids, based on recent developments and study results. These recommendations aim to provide practical recommendations for the diagnosis, treatment and follow‐up of these ...
Eric Baudin, Alice Durand, Wieneke Buikhuisen, Jaume Capdevila, Martyn Caplin, Christophe M. Deroose, Clarisse Dromain, Antongiulio Faggiano, Pier Luigi Filosso, Gregory Kaltsas, Marco Volante, Thomas Walter, Rocio Garcia‐Carbonero   +12 more
wiley   +1 more source

Fibroblast activation protein (FAP)-targeted radionuclide therapy: which ligand is the best? [PDF]

Eur J Nucl Med Mol Imaging, 2023
Chakravarty R, Song W, Chakraborty S, Cai W.   +3 more
europepmc   +1 more source

Using advanced cell models for targeted radionuclide therapy evaluation: increased efficacy in 3D versus 2D. [PDF]

EJNMMI Res
Klomp MJ, Erkens SE, van den Brink L, van Weerden WM, Dalm SU.   +4 more
europepmc   +1 more source

Preclinical Evaluation of PTK7-Targeted Radionuclide Therapy. [PDF]

Mol Cancer Ther
Lindland K, Westrøm S, Dragovic SM, Li RG, Malenge MM, Ho B, Juzeniene A, Bønsdorff TB.   +7 more
europepmc   +1 more source

Low Radioactivity Levels in Blood Samples After Targeted Radionuclide Therapy: Minimal Radiation Exposure of Healthcare Staff. [PDF]

Biomedicines
Wehmann M, Seifert P, Kühnel C, Drescher R, Gühne F, Freesmeyer M.   +5 more
europepmc   +1 more source

Gadolinium-Based Nanoparticles Sensitize Ovarian Peritoneal Carcinomatosis to Targeted Radionuclide Therapy. [PDF]

J Nucl Med, 2023
Garcia-Prada CD, Carmes L, Atis S, Parach A, Bertolet A, Jarlier M, Poty S, Garcia DS, Shin WG, Du Manoir S, Schuemann J, Tillement O, Lux F, Constanzo J, Pouget JP.   +14 more
europepmc   +1 more source

A Targeted Radionuclide Therapy Facility at a University Teaching Hospital in Singapore. [PDF]

Cureus
Chia KL, Ong SJ, Ong M, Tong M, Loi HY, Ang B, Quek ST.   +6 more
europepmc   +1 more source

Chelator Optimization and Therapeutic Potential of ¹⁸⁸Re-FAPI for FAP-Targeted Radionuclide Therapy. [PDF]

ACS Med Chem Lett
Liang SH.
europepmc   +1 more source

Advances in PSMA-Targeted Radionuclide Therapy for Metastatic Castration-Resistant Prostate Cancer. [PDF]

Cancer Manag Res
Wang J, Yuan H, Xu J, Yang C.
europepmc   +1 more source